(Total Views: 686)
Posted On: 07/08/2022 1:11:26 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Leronlimab, mAb to CCR5, Trims Liver Fat in 14-Week Trial of NASH Patients
https://www.natap.org/2022/EASL/EASL_70.htm?f...dNs1vCqMKg
https://www.natap.org/2022/EASL/EASL_70.htm?f...dNs1vCqMKg
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)